These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Fulminant Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 (AZD1222) Vaccine Administration in a Woman With Obesity: A Case Report. Chou YL; Ling WS; Chiou YH Acta Neurol Taiwan; 2024 Jun; 33(2)():81-85. PubMed ID: 37848232 [TBL] [Abstract][Full Text] [Related]
25. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Favaloro EJ Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513 [TBL] [Abstract][Full Text] [Related]
26. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines. Long B; Bridwell R; Gottlieb M Am J Emerg Med; 2021 Nov; 49():58-61. PubMed ID: 34062319 [TBL] [Abstract][Full Text] [Related]
27. Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany. Thiele T; Weisser K; Schönborn L; Funk MB; Weber G; Greinacher A; Keller-Stanislawski B Lancet Reg Health Eur; 2022 Jan; 12():100270. PubMed ID: 34901912 [TBL] [Abstract][Full Text] [Related]
28. Thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada. Procter TD; Ogasawara H; Spruin S; Wijayasri S; Abraham N; Blaser C; Hutchings K; Shaw A; Ogunnaike-Cooke S Vaccine; 2023 Nov; 41(46):6802-6809. PubMed ID: 37806804 [TBL] [Abstract][Full Text] [Related]
29. Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder. Venier LM; Clerici B; Bissola AL; Modi D; Jevtic SD; Radford M; Mahamad S; Nazy I; Arnold DM Int J Hematol; 2023 Mar; 117(3):341-348. PubMed ID: 36574172 [TBL] [Abstract][Full Text] [Related]
31. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Iba T; Levy JH Trends Cardiovasc Med; 2022 Jul; 32(5):249-256. PubMed ID: 35202800 [TBL] [Abstract][Full Text] [Related]
32. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination. Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292 [TBL] [Abstract][Full Text] [Related]
34. Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer. Connors JM; Iba T Thromb Res; 2022 May; 213 Suppl 1():S77-S83. PubMed ID: 36210565 [TBL] [Abstract][Full Text] [Related]
35. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021. Reilly-Stitt C; Kitchen S; Jennings I; Horner K; Jones R; Makris M; Walker ID J Thromb Haemost; 2021 Sep; 19(9):2263-2267. PubMed ID: 34227230 [TBL] [Abstract][Full Text] [Related]
36. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources. Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of VITT. Pai M Semin Hematol; 2022 Apr; 59(2):72-75. PubMed ID: 35512903 [TBL] [Abstract][Full Text] [Related]
38. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). Gabarin N; Arnold DM; Nazy I; Warkentin TE Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906 [TBL] [Abstract][Full Text] [Related]